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Background: Human genome is enriched with thousands of conserved non-coding elements (CNEs). Recently, a
medium throughput strategy was employed to analyze the ability of human CNEs to drive tissue specific expression
during mouse embryogenesis. These data led to the establishment of publicly available genome wide catalog of
functionally defined human enhancers. Scattering of enhancers over larger regions in vertebrate genomes seriously
impede attempts to pinpoint their precise target genes. Such associations are prerequisite to explore the
significance of this in vivo characterized catalog of human enhancers in development, disease and evolution.
Results: This study is an attempt to systematically identify the target gene-bodies for functionally defined human
CNE-enhancers. For the purpose we adopted the orthology/paralogy mapping approach and compared the CNE
induced reporter expression with reported endogenous expression pattern of neighboring genes. This procedure
pinpointed specific target gene-bodies for the total of 192 human CNE-enhancers. This enables us to gauge the
maximum genomic search space for enhancer hunting: 4 Mb of genomic sequence around the gene of interest
(2 Mb on either side). Furthermore, we used human-rodent comparison for a set of 159 orthologous enhancer pairs
to infer that the central nervous system (CNS) specific gene expression is closely associated with the cooperative
interaction among at least eight distinct transcription factors: SOX5, HFH, SOX17, HNF3β, c-FOS, Tal1beta-E47S, MEF
and FREAC.
Conclusions: In conclusion, the systematic wiring of cis-acting sites and their target gene bodies is an important
step to unravel the role of in vivo characterized catalog of human enhancers in development, physiology and
medicine.
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One of the main emerging challenges for genomics re-
search is to discover all functional regions in the human
genome. The completion of human genome sequencing/
assembly and its annotation using computational and
comparative genomic approaches has led to the cataloging
of ~25,000 protein-coding genes. Key questions now relate
to understanding how the spatial and temporal expression
patterns of these human genes are established at cellular* Correspondence: abbasiam@qau.edu.pk
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reproduction in any medium, provided the orand organismal level [1]. In eukaryotes, transcriptional
regulation tends to involve combinatorial interactions
between several transcription factors, which allow for a
sophisticated response to multiple conditions in the cellu-
lar environment [2,3]. In metazoans the precise spatial
and temporal patterns of gene’s expression also require
enhancer elements, distant regions of DNA that can loop
back to the promoter [4]. To comprehend the molecular
mechanism that governs specific expression patterns, it is
important to identify the distant acting transcriptional
regulatory elements (enhancers) associated with each
predicted gene [5]. Furthermore, the ability to identify
such elements is an essential step toward understandingl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[1]. However, this task remains difficult due to lack of
knowledge of the vocabulary controlling gene regulation
and the vast genomic search space, with many of such dis-
tantly acting enhancers are positioned remotely from their
target gene bodies [6].
Metazoan genes hold extremely intricate regulatory
sequences that direct complex patterns of expression in
diverse cell types, tissues and development phases [7].
Expression of a typical animal gene is likely to be governed
by several distinct enhancer elements that can be located
in 50 and 30 genomic regions, as well as within intronic
intervals [8]. Metazoan cis-regulatory sequences are mod-
ular with each enhancer is responsible for a subset of the
total gene expression pattern and usually mediate expres-
sion within a specific tissue/cell type or developmental
phase/domain [9]. These elements are typically up to
500 bp long and contains binding sites for sequence-
specific several distinct transcription factors [8].
The origin of organismal complexity is often thought to
be the consequence of evolution of novel gene functions
subsequent to gene duplication events [10]. According
to the classical model (describing evolutionary fate of
duplicate genes) one copy of the duplicated gene pair
often degenerates by accumulating deleterious mutations,
whereas the other copy keeps the ancestral function. This
model further predicts that very rarely, one gene copy may
obtain a novel adaptive function, resulting in the preserva-
tion of both duplicates, one copy with the new function
and the other preserving the ancestral function. However,
in numerous cases, empirical data suggest that the fraction
of genes preserved subsequent to duplication events is
much higher than predicted by the classic model. Keeping
in view the regulatory complexity of eukaryotic genes, it
was proposed that complementary degenerative mutations
in distinct regulatory elements of duplicated genes can
assist the preservation of both copies, thus providing long-
term opportunities for the evolution of novel gene func-
tions [11]. Numerous duplicate genes have been confirmed
to evolve following this model of regulatory subfunc-
tionalization. For instance, zebrafish engrailed-1 and
engrailed-1b is a pair of transcription factor genes gen-
erated by a duplication event specifically in the lineage of
teleost fish [11]. Expression pattern analysis revealed dis-
tinct expression domains for zebrafish engrailed paralogs
with engrailed-1 is expressed in the pectoral appendage
bud, whereas engrailed-1b is expressed in the hindbrain/
spinal cord region [11]. The mouse genome harbor single
ortholog (engrailed-1) for both genes of the zebrafish,
which is expressed in both pectoral appendage bud and
hindbrain/spinal cord. Complementary changes in gene
expression domains after gene duplication events appear
to be a general rule rather than exception and such
changes usually happen rapidly after gene duplication [12].Genomic comparison of diverse set of vertebrate spe-
cies revealed many genomic intervals that have remained
conserved throughout the vertebrate lineage [13]. Some
of these sequences correspond to coding genes and non-
coding RNAs, however two third of them are unlikely to
produce a functional transcript [14]. These sequences
fall in the new category of elements, which we collect-
ively call as conserved non-coding elements (CNEs) [14].
These elements are experimentally characterized to har-
bor transcriptional regulatory elements, so involved in
gene expression regulation [15]. Therefore, comparative
genomics based strategies are now being employed to
predict genomic regions harboring transcriptional regu-
latory elements even in the absence of knowledge about
the specific characteristics of individual cis-regulatory
element [16].
To explore the functional significance of conserved
non-coding genomic elements, Pennacchio and coworkers
(2006 & 2008) carried out in vivo enhancer analysis of
hundreds of human CNEs in transgenic mice assay by
using LacZ as a reporter gene [15,17,18]. This data
confirmed the gene regulatory function for ~1000 of these
sequences, directing reproducibly the reporter expression
in diverse set of body tissues at mouse embryonic day 11.5
[17]. To elucidate the significance of this in vivo
characterized catalog of human enhancers in organismal
development, physiology and medicine it is essential to
pinpoint the precise target gene for each of these elements.
Noteworthy, Pennacchio and coworkers (2006 & 2008)
associated the gene regulatory potential of these human
enhancers with the genes harboring them (intragenic) or
their immediate flanking genes (intergenic) [17]. However,
the empirical evidence showed that enhancers regions are
often located at large distances from transcriptional start
site of the genes upon which they act [19]. They may be
located upstream or downstream of target gene, within
introns, in introns of unrelated neighboring genes or can
be found at a distance of 1 Mb or even greater and are still
able to regulate the gene expression in tissue specific man-
ner [20]. Scattering of enhancer elements over larger
regions in vertebrate genomes, impede attempts to assign
precise target gene bodies to functionally characterized
enhancer elements.
In the present study, through combined application of
comparative synteny analyses and reported endogenous
expression pattern investigation we systematically hunt
for the precise target gene bodies of experimentally veri-
fied catalog of human gene enhancers [15]. We concentrate
on deeply conserved human enhancers; by restricting to
192/975 cis-regulatory regions that show sequence conser-
vation between mammals and teleost fish (last common an-
cestor existed 450 million years ago) (Table 1, for detailed
list see Additional file 1: Table S1). By assuming that
syntenic relationship between an enhancer and concerned
Table 1 The association of the human CNE-enhancers with their target gene bodies by comparative syntenic analyses
and through comparison of the reporter expression induced by CNE-enhancers with the reported endogenous
expression patterns of the neighboring genes





Only synteny Synteny along with
expression (MGI in-situ)
39 1 √ √ √ ¯
2 2 √ √ ¯ √
1 1 √ √ ¯ √
1 1 √ √ √ *
41 2 ¯ √ ¯ √
7 3 ¯ √ ¯ √
44 1 ¯ √ √ ¯
56 1 ¯ √ ¯ √
1 1 ¯ √ √ *
This table provides the following information about human CNE-enhancers.
(i) The number of target genes associated with each CNE-enhancer analyzed.
(ii) Whether they are duplicated or not.
(iii) Their association with target gene is supported by either syntenic analysis or by endogenous expression analysis or by both.
* Expression pattern is not known.
MGI: Mouse Genome Informatics.
CNE: Conserved non-coding element.
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(orthologous loci) and duplication events (paralogous loci)
[20], we associated explicitly 85/192 enhancers to single
target gene body (Table 1 and Additional file 1: Table S1).
In those cases where more than one gene maintained con-
serve linkage (human-teleost fish orthologous loci) with sin-
gle enhancer the pattern of reporter expression induced by
an enhancer was compared manually (via image data) with
the reported endogenous expression pattern of syntenically
conserved genes to establish the enhancer-gene relation-
ship. This strategy assisted further in assigning the activity
of 57/192 enhancers to single gene, 43/192 enhancers to 2
target genes and 7/192 enhancers to 3 target genes (Table 1,
for detailed list see Additional file 1: Table S1).
Once the enhancers were assigned to their probable
targets the next, we sought to use these associations as a
training dataset to gauge the maximum distance at which
an enhancer can act upon its target gene body. Further-
more this study aims to define the central nervous system
(brain and spinal cord) specific transcription factor code.
Results and discussion
Predicting target genes for human CNE-enhancers
We devised a rule-based procedure to associate CNE-
enhancers with their respective target gene (see methods).
The human CNE-enhancers opted for this purpose is
conserved over longer evolutionary distance, i.e. between
human and teleost fish. Pennachio and coworkers has
confirmed the gene regulatory potential of these deeply
conserved human elements by employing transgenic
mice assay [15]. Combined employment of comparativegenomics and expression pattern analysis has assisted us
to explicitly assign these human enhancers to their target
gene bodies.
Teleost fish are preferred for syntenic comparison be-
cause synteny comparison of human with closely related
vertebrate species (mammals) often exhibits the con-
servation of large number of genes in the vicinity of the
CNE-enhancer that reflects the short evolutionary dis-
tance and slow rate of neutral divergence among mam-
mals, making it difficult to pinpoint the target gene body
of functionally defined human enhancer elements. For
instance, comparative analysis of an enhancer region
(VISTA enhancer ID: hs110) residing on Homo sapiens
autosome 7 (Hsa7: 21,003,280-21,004,750) revealed its
conserved syntenic association with paralogous genes
SP4 and SP8 in mouse, chicken and frog (Figure 1A).
Furthermore, reported endogenous expression pattern
(MGI:RNA in-situ hybridization) of both SP4 (brain and
spinal-cord) and SP8 (brain and spinal-cord) exhibits
harmony with the CNE-enhancer induced LacZ expres-
sion in transgenic mice assay (Figure 1A). Thus, tetrapod
specific synteny comparison and endogenous expression
pattern inspection of bracketing genes fails to assign
the precise target gene body. To solve the puzzle,
orthologous teleost fish loci were included in the synteny
comparison (Figure 1B). Careful inspection of genes in
the neighborhood of fish CNE_SP8-SP4 revealed that
only SP8 gene maintains the syntenic association with
this enhancer in zebrafish, medaka, stickleback and
tetraodon (Figure 1B). It therefore appears that SP8 gene































Figure 1 Human CNE-enhancers associated with target genes using orthology mapping. (A) Comparative syntenic analysis of human,
mouse, chicken and frog orthologous loci depicts the conserved presence of both the paralogous SP4 and SP8 in the nearest vicinity of the
CNE-enhancer (hs110: light green vertical line). Analogy in the expression pattern of the CNE-enhancer and both of these paralogs suggest the
association of this CNE-enhancer with both SP4 and SP8. (B) Increasing the depth of our synteny comparison by including orthologous loci from
teleost fish lineage, it became evident that only SP8 maintains its physical linkage with the CNE-enhancer in fish. Based on uninterrupted physical
proximity over longer period of evolutionary time (450 Myr) SP8 was considered as probable target for this CNE-enhancer. Genes are color-coded.
Direction of arrow depicts the direction of gene transcription. Light green vertical line depicts the position of CNE-enhancer. Horizontal black line
depicts scale.
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we pinpointed specific target genes for the total of 192
human CNE-enhancer elements (Table 1, for detailed list
see Additional file 1: Table S1).
Gene duplication is thought to be a major driving force
in evolutionary innovation by providing raw material from
which novel gene functions and expression patterns may
arise [21]. Estimation of duplication pattern of selected set
of human CNE-enhancers (192) revealed that 17/192
(8.85%) CNE-enhancers have duplicated copies in both
teleost fish and tetrapod representatives. 20/192 (10.42%)
have duplicated copies only in teleost fish representatives
whereas 6/192 (3.12%) CNE-enhancers have duplicated
copies only in human/tetrapods (Figure 2A). Duplicated
CNEs enable us to unambiguously associate the total of42/192 human enhancers to their respective target gene
only on the basis of synteny comparison (Table 1), because
a gene undergoes duplication with all of its cis-regulatory
elements making genomic regulatory blocks (GRBs) which
also harbor some bystander genes which get depleted from
GRBs over evolutionary time (Figure 2A and Figure 3A).
Thus only duplicated enhancers retain with paralogous
copies of their target genes (Figure 2A and Figure 3A). For
instance, in a BLAST search of a CNE-enhancer (hs230)
residing on Hsa5 (158,340,962-158,342,611) significant hits
were found on two other human chromosomal locations,
i.e. Hsa10 and Hsa20. While comparing the human paralo-
gous loci architecture, 2 Mb on each side of the CNE,
triplicate CNE copies were found to exhibit syntenic asso-
ciation with three paralogous genes of EBF family, i.e.
Figure 2 Human CNE-enhancers duplication history and their
genomic range of action. (A) This pie chart shows the extent of
duplication events in our selected subset of CNE-enhancers
(192 enhancers in total). The majority of our selected enhancers are
unduplicated. About 10% of the enhancers have duplicated copies
only in teleost fishes, 9% are duplicated before teleost-tetrapod split
and 3% enhancers have duplicated copies only in human/tetrapod.
(B) This pie chart represents the distribution of distances between
CNE-enhancers and target gene bodies to estimate the optimal
distance at which an enhancer can access its concerned promoter.
About 19% of enhancers are within the introns of their predicted
target gene bodies, 24% are within a range of 0-200 kb, 17% are at a
distance of 201-400 bp, 10% lie in the range of 401-600 kb, 14% in
the range of 601-999 kb and 16% of the enhancers are located at
distance of >1 Mb from their target genes.
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Resuming the analysis we searched out orthologous
counterparts of these human triplicated CNE-enhancers in
teleost fish genome (zebrafish, Fugu, medaka and stickle-
back). Intriguingly, like human genome this enhancer
element was found to occur in multiple copies in each of
the teleost genome analyzed: four copies in zebrafish, three
copies in Fugu/stickleback and two copies in medaka
(Figure 3A). Careful inspection of genic contents around
paralogous copies of fish CNEs revealed that like human
genome only EBF family members maintain physical
linkage with each copy of this enhancer in teleost fish. Dif-
ferential loss of bystander genes like MGMT, IL128 and
RNF from the enhancer containing orthologous and par-
alogous loci explicitly leads to the conclusion that
this human CNE-enhancer (CNE_EBF) is controlling thespatio-temporal expression of human EBF family members
(Figure 3A).
Among the unduplicated set of CNE-enhancers (149/
192) 45 regions were assigned to a single target gene
only on the basis of synteny comparison (Table 1, for
detailed list see Additional file 1: Table S1). For example,
BLAST based search of a CNE-enhancer (hs529) resid-
ing on Hsa9 (17,322,200-17,324,371) identified putative
orthologs of this human interval in zebrafish, medaka,
Fugu, stickleback and tetraodon genomes (Figure 3B).
Synteny comparison of human, zebrafish, medaka, Fugu,
stickleback and tetraodon orthologous loci revealed the
differential loss of BNC2, C9orf39 and FOXE1 genes
(positioned in the vicinity of CNE-enhancer) from the
corresponding loci suggesting them as bystanders.
SH3GL2 was the only gene in this human locus which
maintains physical linkage with the CNE-enhancer in all
examined genomes. Therefore, the gene regulatory po-
tential of this CNE-enhancer (CNE_ SH3GL2) was
assigned to human SH3GL2 gene (Figure 3B).
Very often the situation arose when syntenic compari-
son alone was not sufficient to pinpoint single target be-
cause more than one gene were showing conserved
syntenic association with the CNE-enhancer element in
all evaluated genomes (Additional file 2: Figure S1). In
this situation, reporter expression pattern induced by
CNE-enhancer was compared manually (via images)
with the reported endogenous expression pattern of can-
didate neighboring genes. Analogy in the expression pat-
tern of CNE-enhancer and one of the many conserved
genes solved the puzzle (Additional file 1: Table S1 and
Additional file 3: Table S2). This strategy enabled us to
assign a single target gene to 56/149 unduplicated CNE-
enhancers (Table 1). For instance, during the syntenic
comparison of the orthologous loci of human CNE-
enhancer (hs858) on Hsa19 (30,747,057-30,748,648), two
genes TSHZ3 and ZNF536 are considered as putative
target genes because both of them showed conserved
syntenic association with the CNE-enhancer (Figure 4A).
However, when expression pattern of TSHZ3 and
ZNF536 was monitored only ZNF536 showed harmony
in expression with the CNE-enhancer (Figure 4A).
In 48/149 unduplicated CNE-enhancers we noticed
that more than one syntenically conserved gene (2 or 3)
are showing analogy in expression pattern with the CNE-
enhancer. In this case, two or more genes are declared as
target for the relevant CNE-enhancer (Table 1). For
instance, a human CNE-enhancer (hs1305) on Has8
(80,874,361-80,876,746), revealed conserved syntenic asso-
ciation with HEY1 and STMN2 in all the compared
orthologous loci (Figure 4B). Furthermore, reported en-
dogenous expression pattern of both of these genes
matches with the reporter expression pattern induced by
the CNE-enhancer (Additional file 3: Table S2). Therefore,
Figure 3 Predicting the target genes of human enhancers by paralogy and orthology mapping of locus architecture. (A) CNE-enhancers
when duplicated are retained with their target genes. Comparing the genic content of CNE-EBF containing paralogous loci in human genome and
their orthologous loci in multiple fish lineages unmistakably suggests that duplicated copies of human CNE-EBF enhancer (hs230) are associated with
the regulation of paralogous copies of EBF family members, i.e. EBF1, EBF3 and EBF4. (B) Unduplicated CNE-enhancer (hs529) is associated with its
target gene SH3GL2 by tracing the differential loss of unrelated bystander genes among orthologous loci. Genes are color-coded. Direction of arrow
depicts the direction of gene transcription. Light green vertical line depicts the position of CNE-enhancer. Horizontal black line depicts scale.
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this human enhancer region (Figure 4B).
Range of action of human cis-acting sites
Once the enhancers were assigned to their probable
targets we then set out to use these associations as a
training dataset to gauge the maximum distance at
which an enhancer can act upon its target gene body.
Distance between the enhancer and its target gene is of
significant importance because it is an important aspect
to understand regulatory mechanism of CNEs and there
are also several human genetic disorders that are
associated with the disruption in the genomic distance
between enhancer and its associated gene [20]. We
estimated the percentage of human CNE-enhancers
whose target gene bodies are positioned within the
ranges, e.g. 0-200 kb, 201-400 kb, 401-600 kb, 601-
999 kb and even >1 Mb (Figure 2B). We also counted
the number of CNEs positioned within the intronic
intervals of their target genes. These results show that a
substantial proportion of human enhancers (36/192) res-
ide within the intronic interval of genes they regulate(intragenic) (Figure 2B). Our data further shows that
more than a third of human enhancers (77/192) are
> 400 kb away from their assigned gene body (Figure 2B).
Intriguingly, 40% of these long-range enhancers (31/77)
have predicted targets at a distance of >1 Mb. Among
these extreme long-range enhancers (31 enhancers) nine
are positioned >1.5 Mb away from their target genes
(Additional file 4: Table S3). For instance, comparative
syntenic analysis of a human CNE-enhancer (hs191) res-
iding on Chr5q14.3 (91,036,888-91,038,899) and com-
parison of reported endogenous expression pattern of
neighboring genes revealed that this cis-acting site
regulates the hindbrain specific expression of human
NR2F1 gene from a distance of 1.9 Mb (Figure 5).
It is often assumed that cis-acting regulatory sites act
on the nearest neighboring genes and therefore the con-
ventional search space for enhancers includes immediate
upstream or downstream intervals of genes of interest.
However, some examples exist where enhancers skip
nearby promoters and specifically act on distantly
located genes [19]. For instance, tissue specific expres-
sion of developmentally important SHH [20] and SOX9
Figure 4 CNE-enhancer induced reporter expression was compared with the endogenous expression of neighboring genes to find
their probable target. In those cases where comparative synteny analysis alone was not sufficient to establish unambiguous associations among
CNE-enhancers and their target gene bodies, we carefully compared the CNE-enhancer induced reporter expression pattern with the reported
endogenous expression pattern of neighboring genes. (A) Both TSHZ3 and ZNF536 genes depict conserved syntenic associations with a human
CNE-enhancer (hs858), suggesting either or both of these genes are under the regulatory control of this enhancer. However comparing the
reporter expression induced by this CNE-enhancer with the reported endogenous expression pattern of TSHZ3 and ZNF536 depicts a precise
analogy in the expression domain of ZNF536 and this enhancer interval. (B) CNE-enhancer (hs1305) within an intron of human MRPS28 gene is
not associated with the promoter of the same gene, rather applying the same strategy discussed above in panel A we infer that this
CNE-enhancer is acting at a distance of ~150.8 kb on HEY1 and STMN2 genes. Genes are color-coded. Direction of arrow depicts the direction of
gene transcription. Light green vertical line depicts the position of CNE-enhancer. Horizontal black line depicts scale.
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positioned ~1 MB away from their transcription start
site. Intriguingly, in this study substantial proportion
(31/192) of enhancer-target gene associations are
established at ≥ 1 Mb genomic interval and thus firmly
establishing the fact that long-range spatial interaction
among regulatory sites and their target gene bodies
are not rare exceptions but occur on pervasive scale
(Figure 2B and Additional file 4: Table S3). Consequently,
this would imply that assignment of full complement of
regulatory sites that act upon a single gene of interest can
be seriously impeded by extreme site separation and this
could in turn hinder attempts to associate disease causing
non-coding mutations with their concerned gene bodies.
Rigorously defined enhancer-target gene associations
established in this study enable us to underscore the ideathat linear proximity (among regulatory sites and target
genes) rule is inadequate for the identification of cis-
regulatory regions and thus extends the previously
established maximum search space for enhancers from
2 Mb DNA template around the gene of interest to 4 Mb
DNA template (2 Mb on either side) around the gene of
interest (Additional file 4: Table S3).
CNS specific transcriptional factor code
In higher eukaryotes the cell type specific or temporal
specific influence of enhancer on their target genes is
implemented through interactions of these cis-regulatory
modules with TFs. The co-occurrence of distinct set of
TFs (heterotypic clustering) with each type of binding
site represented many times within the same regulatory
























Figure 5 Human enhancer regions can access their target
promoters from a distance of ~2 MB. Evolutionary conserved
syntenic association between a CNE-enhancer (hs191) and human
NR2F1 and harmony in their expression pattern domains in mice
infers the functional association among them. The distance between
the transcription start site of human NR2F1 and concerned cis-acting
site is ~2 MB. Genes are color-coded. Direction of arrow depicts the
direction of gene transcription. Light green vertical line depicts the
position of CNE-enhancer. Horizontal black line depicts scale.
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portant feature of homotypic site clustering is that it
facilitates cooperative binding of factors that interacts to
moderate or weaker sites [24]. Numerous transcription
factors work in concert to regulate target genes in a de-
velopmental, cell, or tissue-specific manner. Typically,
specific type of cooperativity (similar set of distinct TFs)
is required to regulate diverse set of genes exhibiting tem-
porally and spatially synchronized expression (co-expressed
genes) [25,26]. For example, skeletal-muscle-specific ex-
pression of distinct gene sets has been associated with the
cooperative interactions among at least five TFs: Mef-2,
Myf, Sp1, SRF, and Tef [27]. Prediction of transcription
factor cooperativity has been carried out in yeast and
human but unfortunately our current knowledge about
combinations of TFs that contributes to the tissue specifi-
city of cis-regulatory modules is limited. This in turn has
limited the large scale bioinformatics study of tissue-
specific gene regulation.
Here we seek to identify TFs that act cooperatively to
define CNS (central nervous system) specificity of an en-
hancer. For this purpose, among the selected subset ofdistant acting developmental enhancers we choose the
one for which reproducible CNS-specific activity has been
shown in vivo in E11.5 mouse embryos [15]. This data set
consists of 159/192 elements, majority (118/159) of which
are explicitly associated with single target gene (Table 1).
Given the fact that a typical binding motif for TF can be
as short as 5-8 bp, in silico matches to such short motifs
occur frequently by chance alone, with many of these
predicted sites presumably non-functional. Therefore, a
major challenge in computational identification of such
motifs that must be overcome is distinguishing functional
TFBSs from spurious motif matches. In order to better de-
fine biologically relevant combinations of TFs, while ana-
lyzing each brain specific cis-regulatory module for an
input set of known TFs we focused on: (i) evolutionary
conservation of each enhancer across human and mouse
lineages; (ii) conserved binding motifs that occurred more
than once in an enhancer. This stringent criterion com-
bining the technique of phylogenetic foot printing and
possibilities of occurrence of homotypic interactions
within typical metazoan enhancers reveals that the brain
specific cis-regulatory modules have evolutionary con-
served binding site preferences for SOX5, HFH, SOX17,
c-FOS, HNF3β, c-REL, MEF2, nMYC, USF, FREAC,
Tal1beta-E47S, NF-kappaB, AML1 and ARNT, the four-
teen transcriptional factors (Additional file 5: Table S4).
The CNE enhancers across the 14 TFs of training data
set are then developed as a matrix X15914 and non-
conserved/non-coding elements (Additional file 6: Table
S5) across the 14 TFs of the control data set developed
as a matrix Y 10014 . The two correlation matrices of the
training and control data sets developed as RX = [rij
2] and
RY = [rij
2] and revealed the pattern of TFs existing in the
two comparative data sets (Additional file 7: Table S6). In
the training data set a specific pattern of TF interactions is
exposed by the formation of three distinctive groups of
TFs with strong within and poor or no correlation among
the groups, leaving aside two TFs: Tal1beta-E47S and
MEF. These two are neither correlated between nor with
any other member of the three groups formed. Here the
findings of RX = [rij
2] may be grouped into three clusters
configuration as,➢ Cluster-1: n-MYC, ARNT, USF (each rij
2 higher than
69%)
➢ Cluster-2: c-REL, NF-kappaB (r2 is 30%)
➢ Cluster-3: FREAC, AML-1, c-FOS, HNF3-β, SOX17,
HFH, SOX5 (12% ≤ rij
2 ≤ 54%)
The RY = [rij
2] present findings in contrast with the
above three cluster structure found from the RX = [rij
2].
Apart from a highly correlated group of three TFs similar
to cluster-1, not any other group structure is seen with the
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data set. A presumption of a non-interactive pattern of
TFs in the control data set may be considered here.
The probability table (Table 2) provides a similar per-
ception of a group structure of TFs present in the
X15914 and non co-occurrence pattern of TFs in Y 10014
. It is readily seen that the least of an P(TF)i in group-2
(the above cluster-3) of the training data set is not less
than 59% (Table 2). Higher the P(TF)i more likely is the
co-occurrence of TFs in the elements (the CNS enhancers
in the training and non-conserved/non-coding elements in
the control data sets). In contrast, a lesser P(TF)i may not
be attributed to a less likely co-occurrence pattern of a TF.
Since a P(TF)i simply defines a degree that a TF is likely to
occur in an element, so lower P(TF)i are not mere
reflections of less likely co-occurrence of TFs within the
elements. Yet the likelihood of the co-occurrence pattern of
these TFs cannot be overruled, since any TF that is less
frequent across the elements may be co-occurring with
another TF or TFs. The occurrence of all the fourteen TFs
in the control data set are less frequent with 0.06 ≤ P(TF)i
≤ 0.51 compared with the proportion of TFs in group-2 of
the training data set (Table 2). This quantifies the signifi-
cance of likely co-occurrence of TFs in group-2 of the
training data set.
Final identification of the cluster structures in the
binding site preferences of the training and control data
set is achieved with the application of Principal Compo-
nent Analysis (PCA). The PCA on X15914 and X10014Table 2 Probability table of transcription factor binding
sites in training and control data sets




1 Tal1b-E47S 54/159=0.34 6/100=0.06
2 NF-kappaβ 29/159=0.18 10/100=0.10
3 n-MYC 74/159=0.46 7/100=0.07
4 ARNT 61/159=0.38 17/100=0.17
5 USF 61/159=0.38 7/100=0.07
6 c-REL 58/159=0.36 20/100=0.20
7 MEF 55/159=0.35 10/100=0.10
8 FREAC 94/159=0.59* 14/100=0.14
9 AML-1 94/159=0.59* 25/100=0.25
10 c-FOS 119/159=0.74* 23/100=0.23
11 HNF-3beta 119/159=0.74* 31/100=0.31
12 SOX17 136/159=0.85* 44/100=0.44
13 HFH 150/159=0.94* 51/100=0.51*
14 SOX-5 151/159=0.95* 44/100=0.44
* TFs with P(TFi) greater than 0.50 defined as group-2. The table present Sr. No 8
to 14 in Training data set as the only group of TFs with high probability of TFs so
the most likely co-occurring TFs in CNS brain specific enhancers compared to TFs
with P(TFi) less than 0.5 in training and control data sets.using RX = [rij] and RY = [rij] respectively validated the
heterotypic clustering pattern of TFs perceived so far in
the training data set, in a 3D loading plot of the first
three principal components (PCs). The first three PCs
explained 60% of the total variation present in the
patterned correlated data set of X15914 . The 3D loading
plot (Figure 6B) of the first 3 PCs derived from PCA on
control data exposed a scenario of non-interactive pat-
tern of TFs across the non-conserved and non-coding
elements, a wide contrast to the interactive pattern of
TFs across the CNS enhancers in the training data set
(Figure 6A). The 3D loading plot (Figure 6A) exhibits
clarity of three distinct sets of closely packed TFs, i.e.
three cluster configurations of TFs. The cluster configu-
ration presented coincide with the cluster configuration
perceived in RX = [rij
2], in addition to merging the two in-
significant TFs: Tal1beta-E47S and MEF in cluster-3.
The two TFs with P(TF)i less than 0.36 are co-occurring
with the TFs packed in cluster-3 so are merged in it.
Thus cluster-3 in the training data set takes the form,❖ Cluster-3: Talb-E47S, MEF, FREAC, AML-1, c-FOS,
HNF3-β, SOX17, HFH, SOX5.
We may conclude that there are three distinct clusters
of TF internally interactive and showing brain specific
cis-regulatory modules binding site preferences in the
training data set. The statistical significance of pattern of
TFs interactions in the training data set exposed are well
supported by the probability table (Table 2), the correl-
ation matrix (Additional file 7: Table S6) interpreted as
R = [rij
2] and are further statistically significant with the
control results of non-conserved and non-coding elements.
To validate in silico predicted tissue specific TF code,
an essential prerequisite is to depend upon experimentally
determined relevance of TFs to the tissue of interest.
Therefore, we consulted the literature and MGI [28] Gene
Expression Database (GXD) project, and investigated the
reported RNA in-situ hybridization based endogenous
gene expression pattern for each of the predicted TF. In-
triguingly, we found that our predictions are enriched in
CNS specific expression during early mouse development
(Table 3). Thus biological knowledge provides a crucial sup-
port to the quality of in silico predicted cooperation among
specific set of transcription factors to regulate the CNS spe-
cific co-expressed genes. This analysis not only provides the
list of TFs that may play a crucial role in CNS specific gene
regulation but also provides information about cooperation
between distinct set of factors (Figure 6). Furthermore,
CNS specific transcription factor code defined in this study
can act as a priori knowledge in large scale bioinformatics
studies aimed at identifying cis-regulatory modules involved
in neural tube specific gene regulation.
Figure 6 3D loading plots. A: Central nervous system specific human enhancers exhibit three distinctive and internally compact clusters
exposing the interactive pattern of TFBSs. B: The control data set of human non-conserved and non-coding elements do not present any vivid
cluster structure for the fourteen TFBSs that formed internally closely packed clusters in CNS specific enhancers (A), thus elucidating the
significance of clusters in panel A. TFBSs are color coded.
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Metazoan cis-regulatory landscape is complex, with
modular organization and widespread spatial distribu-
tion around the target genes. This complexity hampers
attempt to localize and catalog the entire repertoire of
enhancers that orchestrate spatially and temporally di-
verse expression patterns for single gene of interest. Re-
cent relatively high throughput transgenic mice assay
based studies generated the genome-wide experimentally
validated data set for hundreds of human enhancers.Table 3 List of transcription factors having over-representativ
Transcription factor Protein-related information
AML1 RUNT-type transcription factor
ARNT Helix-loop-helix DNA-binding
cFOS Basic-leucine zipper (bZIP) transcription fact
c-REL Immunoglobulin-like fold
FREAC Winged helix-turn-helix transcription repress
HFH Winged helix-turn-helix transcription repressor
HNF3B Winged helix-turn-helix transcription repressor
MEF2 myocyte-specific enhancer factor 2A
NF-KappaB Immunoglobulin-like fold
nMYC Helix-loop-helix DNA-binding
SOX17 High mobility group, HMG1/HMG2
SOX5 High mobility group, HMG1/HMG2
Talbeta-E47S Helix-loop-helix DNA-binding
USF Helix-loop-helix DNA-binding
This table also provides references of literature (last column) that addresses the typRegulatory activities of each of these enhancers were
confirmed through enhancer induced LacZ reporter ex-
pression in E11.5 mice embryos and tissue specificity of
expression was also described. Such genome-wide
collections of enhancer data set are expected to contrib-
ute immensely in understanding i) structural anatomy of
metazoan enhancers ii) mechanisms of enhancer-target
gene interactions iii) comprehensively catalog the genetic
regulatory circuits for developmentally critical genes iv)
role of cis-regulatory mutations/alterations in developmente occurrence in brain specific cis-acting sites
Known endogenous expression pattern Source
spinal cord, hindbrain [29,30]
spinal cord, forebrain, midbrain, hindbrain [31,32]
or hindbrain [33,34]
CNS (components not defined yet) [35,36]
or CNS (components not defined yet) [37,38]
DNA CNS (components not defined yet) [39,40]
DNA Spinal-cord, forebrain midbrain, hindbrain [41,42]
forebrain, hindbrain [43,44]
spinal cord, forebrain, midbrain, hindbrain [45,46]
spinal cord, forebrain, midbrain, hindbrain [47,48]
spinal cord, forebrain, midbrain, hindbrain [49]
spinal cord, hindbrain, midbrain [50,51]
spinal cord, forebrain, midbrain, hindbrain [52,53]
spinal cord, forebrain, hindbrain [38,54]
e/function and endogenous expression pattern of transcription factors.
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acterized enhancers for variety of biological applications
requires their systematic association with target gene bod-
ies. This study is an attempt to systematically associate
subset of these functionally defined enhancers with their
target genes and thus establishing regulatory interactions
for dozens of human genes. These explicit associations
would enable the screening of this subset of enhancers for
those pathogenic mutations not affecting the coding
sequences of concerned genes but disrupting the function-
ality of these cis-acting regulatory sites and thus altering
temporal, spatial and quantitative aspects of gene expres-
sion. Furthermore, assigning enhancers to bona fide target
genes assisted us to gauge maximum range at which an
enhancer can access its target promoter and delineated
the fact that in human genome long-range regulatory
interactions occur more frequently and involve longer
distances than was previously anticipated. Maximum range
of enhancer action reported in this study should serve as a
guideline when analyzing the chromosomal deletions/
rearrangements associated disorders; such as locus alter-
nations are known to disrupt communication among dis-
tant regulatory sites and their target genes.
Gene regulation is exerted by cooperative interactions
among TFs that binds to clusters of sites within cis-
regulatory regions. Distinct cis-regulatory modules direct
reporter expressions selectively in a particular cell/tissue
specific manner are likely to interact with similar set of
TFs and thus defining the TFBSs code for co-expressed
genes. In this respect, given the abundant set of ex-
perimentally defined regulatory sequences, which is
sufficient to direct expression of a reporter gene in a
cell-specific pattern and list of TFs that are known to be
relevant to that tissue, it is possible to construct bio-
logically relevant, tissue specific, complex heterotypic
TFs cluster model. Under this assumption, among the
CNE-enhancers linked to their target genes we analyzed
the large subset of regions that direct gene expression
selectively to CNS and defined combinatorial heterotypic
interactions of multiple TFs that are likely to bind to
typical CNS specific cis-regulatory module. This analysis
not only figures out the generalized structure of typical
CNS specific enhancer, but has established TF inter-
action network that can be used as training data set for
large scale identification of CNS specific enhancers.
Methods
In vivo dataset
Experimentally verified catalog of human enhancers which
is the basis of this study was obtained from VISTA Enhan-
cer Browser [17]. The core dataset of the VISTA Enhancer
Browser consists of experimental in vivo data of human
and mouse tissue-specific enhancers [17]. These enhancer
regions were initially identified by evolutionary sequenceconservation or by ChIP-seq [17]. Subsequently these
putative enhancer sequences are tested in a transgenic
mouse assay to validate their in vivo function and to deter-
mine their tissue specificity [17]. Elements that show re-
producible and consistent LacZ reporter gene expression
among at least three mouse embryos are presented as
positive enhancers elements, whereas elements for which
no reporter expression is observed among a minimum of
five transgenic embryos are defined as negative [17]. The
dataset of positive embryos is reported comprehensively
in terms of sequence coordinates, flanking genes, anno-
tated expression patterns and details of reproducibility of
each structure, images of individual embryos, and series of
histological sections [17]. Currently this database host ex-
perimentally confirmed 975 human enhancer sequences,
directing reproducibly the reporter expression in diverse
set of embryonic domains at embryonic day 11.5. We
restricted our analyses to 192 human-teleost fish con-
served sequences (Table 1, for detailed list see Additional
file 1: Table S1). For each of the candidate enhancer ele-
ment, we retrieved from VISTA enhancer browser infor-
mation such as, genomic sequence, VISTA enhancer ID,
conservation depth, and name of neighboring genes, tissue
specificity and image data (Additional file 3: Table S2).
Assigning the target gene to human CNE-enhancers
In order to associate each of the selected subset of
human CNE-enhancer with their bona fide target gene,
we analyzed the neighboring genomic context using the
UCSC [55] and Ensembl genome browsers [56] and
drafted a locus map depicting the flanking genes span-
ning at least 2 MB interval on either side of CNE-
enhancer (Additional file 2: Figure S1). The sequence
similarity of selected subset of CNEs between the human
and the teleost fish genome suggests that they are func-
tional in both lineages. It would be appropriate then to
speculate that the target genes would also be the same
in both species. Given this assumption, comparative pic-
ture of these CNE-enhancers bearing human synteny
maps was observed in currently available teleost genome
(zebrafish, tetraodon, stickleback, medaka and Fugu) by
using Multi-species view option at Ensembl genome
browser [56]. This allowed us to map carefully the gen-
omic context of evolutionary conserved human enhancers
in corresponding zebrafish, tetraodon, medaka, stickle-
back and Fugu loci (Additional file 2: Figure S1). Among
these anciently diverged genomes (human-teleost fish,
>450 Mya) uninterrupted physical linkage between CNE-
enhancer and one or more neighboring genes was taken
as an evidence of functional association (Additional file 1:
Table S1 and Additional file 2: Figure S1). To further con-
firm these associations, for one or more genes depicting
evolutionary conserved physical association with CNE-
enhancer, the endogenous expression pattern of the
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ferred available gene expression obtained by RNA in-situ
hybridization. Reporter gene expression induced by the
selected CNE-enhancer is also captured from the VISTA
enhancer browser database [17]. We manually compared
the image data of transgenic mouse embryos expressing
LacZ reporter gene under the influence of CNE-enhancer
element with the RNA in-situ hybridization based en-
dogenous expression data of genes residing in the
neighborhood of enhancer sequence (Additional file 3:
Table S2).
Duplicated copies of selected subset of CNE-enhancers
(dCNEs) were searched through BLAST based similarity
searches at Ensemble and UCSC genome browsers
[55,56]. We categorized the duplicated enhancers into
those, with duplicated copies only in fish lineage (only a
single counterpart in human), duplicated copies only in
human (only a single counterpart in fish), and the ones
that contains duplicated copies in both fish and human
lineages (Figure 2A). Duplicated CNE-enhancer facil-
itated further, to link them explicitly with their target
gene through paralogy mapping, i.e. by identifying the
genes that have paralogs in the genomic regions that
harbor at least two dCNEs from the same family. Para-
logy relationship among target genes of duplicated set
of enhancers was generated by using paralogy predic-
tion pipeline of Ensembl genome browser where max-
imum likelihood phylogenetic gene trees (generated by
TreeBeST) play a central role [57].Estimation of range of action of human CNE-enhancers
Orthology mapping, paralogy mapping and expression
pattern analysis helped in assigning bona fide target
genes to total of 192 human CNE-enhancers. These
large numbers of enhancer-target gene associations
enables us to define the genomic range of regulatory ac-
tivity for human enhancer sequences. For this purpose
we calculated the distance between the CNE-enhancers
and transcriptional start site of their predicted target
genes and then examined the distribution of distances.
We partitioned the range of enhancer action as, CNE-
enhancers embedded within intronic intervals of target
gene (intragenic), CNE-enhancers whose target gene lies
within the ranges, e.g. 0-200 kb, 201-400 kb, 401-600,
601-999 and >1 Mb (Figure 2B). Our data shows that
36/192 (18.75%) enhancers are located within the in-
tronic interval of genes they regulate, 47/192 (24.48%)
enhancers are within a range of 0-200 kb from their
assigned gene, 32/192 (16.67%) enhancers are within a
distance of 201-400 kb, 19/192 (9.89%) positioned within
401-600 kb from their associated gene, 27/192 (14.06%)
separated by a distance of 601-999 kb from their target.
Intriguingly, 31/192 (16.14%) enhancers were found toact on their concerned gene body from a distance of
>1 Mb (Figure 2B and Additional file 4: Table S3).Transcription factor analysis
To establish the central nervous system (CNS) specific
transcriptional factor (TF) code we selected 159/192
the subset of human CNE-enhancers that were shown
to drove expression in various domains mouse CNS
(Additional file 5: Table S4). For this purpose the tech-
nique of phylogenetic foot printing was employed on
human and mouse orthologous enhancer regions to
track the occurrence of evolutionary conserved grouping
of transcription factor binding sites (TFBSs) in experi-
mentally verified subset of brain specific enhancers
(Additional file 5: Table S4).
Mouse orthologs of human enhancers were obtained
through BLAST based similarity searches. Human-mouse
conserved transcription factor binding sites in each CNE-
enhancer were detected with computer program ConSite
[58]. The ConSite screen for conserved TFBSs was
performed against the JASPAR database with 85% conser-
vation cutoff, 60 bp window size and 75% transcription
factor score threshold settings.
To track cooperative heterotypic interaction among
distinct set of TFs within brain specific enhancers, suit-
able statistical methodologies were employed for their
identification and verification. We formulated a multivari-
ate data matrix with n (rows) as the sample of enhancers
and p (columns) the number of TFs for training and con-
trol data sets (for control data set see Additional file 6:
Table S5). For the materialization of the known biological
background that occurrences of TFs in sample of en-
hancers are not mutually exclusive, the repeated occur-
rence of a TF is determined by finding the individual
probability of the occurrence of a TF (P(TF)i in a sample).
Looking for the patterns and structures in TFs, primarily
the training data matrix of 159 enhancers across 14 TFs
X15914ð Þ and control data matrix of non-conserved/non-
coding elements Y 10014ð Þ are subjected to a two step ex-
ploratory data analysis. Computation of probabilities of
TFs in (Table 2) and correlation matrices RX = [rij
2] (lower
diagonal in Additional file 7: Table S6) and RY = [rij
2]
(upper diagonal in Additional file 7: Table S6) complete
the two steps employed for the initial exploration of
patterns of TFs in the control and training data sets re-
spectively. The probability table (Table 2) is a classified
presentation of P(TF)i with P(TF)i < 0.5 as members of
group-1 and for P(TF)i ≥ 0.5 members of group-2 in the
training and control data sets.
The correlation matrices of the data sets are desirable
to define clusters of TFs that may covary together
among all possible pairs of TFs. For the purpose, the
squared correlation coefficient (R = [rij
2]) is interpreted as
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among the variables (Additional file 7: Table S6) [59,60].
Principal Component Analysis (PCA), a powerful
multivariate exploratory tool is used to identify patterns
in specifically high (P) dimension, interrelated data sets
and express the data sets by highlighting their similar-
ities and differences. For multivariate data sets that
are interrelated, appropriate application of PCA is using
R = [rij] matrix for eigen analysis. Therefore, PCA will be
used as a means of constructing an informative graphical
representation of the data set by projecting the data onto
a lower dimensional space. In the study, control and
training data will be presented in a three dimensions
(3D) subspace of the first three PCs [61,62]. The PCs
derived by the eigen analysis of correlation matrix (R = [rij])
is a linear combination of the original p variables (the TFs)
and each PC uncorrelated with the other, meaning these
are the new transformed data expressed in terms of the
patterns existing in the original data set. The total PCs
derived are equal to the number of original variables
present in the dataset. The p PCs formed are with decreas-
ing order of magnitude of variance of the total variation in
the data sets. Thus the first three PCs capturing most of
the variation in the data set is visualized in a 3D repre-
sentation. The coefficient of the variables in each of the
linear combination, i.e. the PC is defined as loadings. The
magnitude of these loadings represents the importance of
each variable present. Thus a 3D representation of the
loadings of the first three PCs will identify any cluster
structure present in the variables (the TFs), exhibiting the
co-occurring pattern of TFs in the control and training
data sets.
The comparative analysis of control and training is of
major significance in the validation of clusters of known
TFs highly represented in human brain specific enhancers.Additional files
Additional file 1: Table S1. Evidences for CNE-enhancer and Target
gene Association.
Additional file 2: Figure S1. Comparative synteny analysis of genomic
regions containing human CNE-enhancers.
Additional file 3: Table S2. Describes the names of CNE enhancers as
given by (http://enhancer.lbl.gov/), human chromosome location,
coordinates (hg19), status of conservation location with respect to
putative associated genes. Molecular function/biological process and
endogenous expression pattern(as described in Mgi (http://www.
informatics.jax.org/) of candidate associated genes is also given. The last
column describes the reporter expression induced by human CNE
enhancer in transgenic mice assay as describes by (http://enhancer.lbl.gov/).
Additional file 4: Table S3. List of CNE-enhancers which reside
>1.5 Mb apart from their target gene.
Additional file 5: Table S4. Transcription factor binding sites analysis.
Additional file 6: Table S5. Transcription factor binding site analysis of
control dataset of human non-coding and non-conserved elements.Additional file 7: Table S6. R = [rij
2] A Correlation Matrix with Lower
Diagonal for Training and Upper Diagonal for the Control data set.
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